MediWeek

A study published recently in The New England Journal of Medicine(NEJM) reported that treatment with dapagliflozin, a sodium–glucose transporter 2 (SGLT2) inhibitor, reduced the risk of cardiovascular (CV) outcomes in patients with heart failure (HF) and left ventricular ejection fraction (LVEF) >40%. The interventional study, Dapagliflozin Evaluation to Improve the Lives of Patients with Preserved […]

A recent study published in JAMA Neurology reported that walking 9,826 steps a day can lower the risk of dementia by half. In addition, steps of higher intensity can further reduce the incident risk. This prospective, observational cohort study, conducted by Del Pozo Cruz B et al. included 78,430 adults (40–79 years of age) from